|Company Name||GENETEC TECHNOLOGY BERHAD|
|Date Announced||31 Jan 2023|
|Category||General Announcement for PLC|
|Subject||NEW ISSUE OF SECURITIES (CHAPTER 6 OF LISTING REQUIREMENTS)
GENETEC TECHNOLOGY BERHAD ("GENETEC" OR THE "COMPANY") PROPOSED PRIVATE PLACEMENT OF NEW ORDINARY SHARES IN GENETEC ("SHARES") TO INDEPENDENT THIRD-PARTY INVESTORS TO BE IDENTIFIED AT A LATER DATE, REPRESENTING UP TO 10.0% OF THE COMPANY'S ENLARGED TOTAL NUMBER OF ISSUED SHARES (EXCLUDING TREASURY SHARES, IF ANY) ("PROPOSED PRIVATE PLACEMENT")
We refer to the Company’s announcements dated 12 January 2023, 13 January 2023 and 30 January 2023 respectively in relation to the Proposed Private Placement. Unless otherwise stated, the terms used herein shall have the same meaning as defined in the said announcements.
On behalf of the Board, CIMB wishes to announce that Bursa Securities had, vide its letter dated 31 January 2023, approved the listing and quotation of up to 71,669,520 Placement Shares to be issued on the ACE Market of Bursa Securities, subject to the following conditions:
1. Genetec and CIMB must fully comply with the relevant provisions under the ACE Market Listing Requirements pertaining to the implementation of the Proposed Private Placement;
2. Genetec and CIMB to inform Bursa Securities upon the completion of the Proposed Private Placement; and
3. Genetec to furnish Bursa Securities with a written confirmation of its compliance with the terms and conditions of Bursa Securities’ approval once the Proposed Private Placement is completed.
This announcement is dated 31 January 2023.